Trusted Collaboration, World-Class Care

Cancer treatment and research breakthroughs require a team effort. We're proud of our collaborations with other nationally recognized cancer centers, healthcare innovators, and physicians like you to deliver world-class treatment for patients living with cancer.
 

From Our Experts

Petros Grivas and Tom Lynch

Oncology Insights Podcast

In each episode of Meet the Greek, Petros Grivas, MD, PhD, talks with cancer experts and scientists from across Fred Hutch — exploring their peronsal stories as well as the latest developments in cancer care and research. Dr. Grivas emphasizes the importance of learning from colleagues, engaging with patients and fostering community partnerships.

Listen or Watch
Jeff Leek

Working Together to Transform Research and Care with Applied AI

We're spearheading a project with three other NCI-designated cancer centers to leverage artificial intelligence technology to uncover new insights. The Cancer AI Alliance — CAIA — includes Dana-Farber Cancer Institute, Memorial Sloan Kettering Cancer Center, The Sidney Kimmel Comprehensive Cancer Center and the Whiting School of Engineering at Johns Hopkins.

Learn More

Timely Insights

Subscribe to our monthly Oncology Insights newsletter to gain timely insights from the experts at Fred Hutch and UW Medicine about cancer research and care as well as updates about our treatments and services. You'll also learn about our upcoming physician education events. 


A potential game-changer in blood and marrow transplantation

A potential game-changer in blood and marrow transplantation

Dr. Marco Mielcarek will collaborate with researchers across three institutions to improve preventative care for graft-vs.-host disease
Hutch NewsSeptember 23, 2026
Prostate cancer genetics, germline testing and expanding access with Dr. Heather Cheng

Prostate cancer genetics, germline testing and expanding access with Dr. Heather Cheng

Oncology Insights with Dr. Petros Grivas - Episode 22
Hutch NewsSeptember 18, 2026
New assay better predicts treatment for two cancers

New assay better predicts treatment for two cancers

Fred Hutch researchers develop HRDefine, a new clinical test to better serve patients with tubo-ovarian and triple-negative breast cancer
Hutch NewsSeptember 15, 2026
Exploring the health impacts of sickle cell trait

Exploring the health impacts of sickle cell trait

A new analysis could expand our understanding of the health conditions associated with a single copy of the sickle cell beta globin gene
Hutch NewsSeptember 14, 2026